Algemeen

Remming van annexine A2 bevordert mitofagie en vermindert hartschade na infarct

Mitofagie is cruciaal bij hartschade en -herstel na een myocardinfarct. Dit onderzoek toont dat remming van annexine A2 de PHB2-gemedieerde mitofagie in cardiomyocyten bevordert, wat hartschade en remodeling na een infarct vermindert.

Abstract (original)

BACKGROUND:Mitophagy is critically involved in cardiac injury and repair after myocardial infarction (MI), whereas the annexin A family plays an important role in mitophagy. However, the intrinsic molecular underpinnings that orchestrate the homeostasis of mitophagy in the infarcted heart remain to be fully characterized. Here, we aimed to evaluate the role of ANXA2 (annexin A2) in cardiac mitophagy in response to MI.METHODS:Transcriptome analyses were conducted to identify differentially expressed genes and enriched pathways. Mitophagy, mitochondrial function, and cardiac injury and remodeling were analyzed in MI mice and neonatal rat ventricular myocytes with cardiomyocyte-specific ANXA2 knockdown or overexpression, as well as in models with ANXA2 knockdown combined with PHB2 (prohibitin 2) silencing. Immunoprecipitation, mass spectrometry, and glutathione S-transferase pull-down assays were used to identify the interacting proteins of ANXA2.RESULTS:We showed that ANXA2 was highly ex

Dit artikel is een samenvatting van een publicatie in Circulation. Voor het volledige artikel, alle details en referenties verwijzen wij u naar de oorspronkelijke bron.

Lees het volledige artikel

DOI: 10.1161/CIRCULATIONAHA.125.077780